AkzoNobel (AKZOY)
(Delayed Data from OTC)
$21.28 USD
-0.26 (-1.21%)
Updated Sep 10, 2024 03:58 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Balance Sheet
Fiscal Year End for Akzo Nobel NV falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,924 | 1,882 | 1,432 | 2,120 | 1,578 |
Receivables | 2,687 | 2,578 | 2,767 | 2,278 | 2,389 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,785 | 1,942 | 1,952 | 1,324 | 1,276 |
Other Current Assets | 145 | 177 | 176 | 63 | 71 |
Total Current Assets | 6,541 | 6,579 | 6,327 | 5,785 | 5,313 |
Net Property & Equipment | 2,158 | 2,073 | 2,130 | 1,852 | 1,904 |
Investments & Advances | 0 | 0 | 211 | 0 | 168 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 570 | 0 | 592 |
Intangibles | 4,417 | 4,290 | 4,366 | 4,060 | 4,060 |
Deposits & Other Assets | 2,313 | 2,282 | 2,456 | 2,986 | 2,085 |
Total Assets | 15,756 | 15,531 | 16,419 | 15,052 | 14,542 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 2,595 | 2,679 | 1,841 | 136 | 189 |
Accounts Payable | 3,174 | 2,951 | 3,488 | 2,947 | 2,695 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 256 | 0 | 220 |
Other Current Liabilities | 406 | 424 | 176 | 450 | 259 |
Total Current Liabilities | 6,176 | 6,054 | 5,761 | 3,533 | 3,362 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,235 | 1,175 | 671 | 1,557 | 438 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3,425 | 3,511 | 2,359 | 3,165 | 2,287 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 961 | 0 | 1,099 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 10,836 | 10,739 | 9,751 | 8,255 | 7,186 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 92 | 92 | 108 | 109 | 112 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 0 | 0 | 0 | 0 | 0 |
Other Equity | 4,828 | 4,700 | 6,560 | 6,688 | 7,244 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 4,920 | 4,792 | 6,668 | 6,797 | 7,356 |
Total Liabilities & Shareholder's Equity | 15,756 | 15,531 | 16,419 | 15,052 | 14,542 |
Total Common Equity | 4,920 | 4,792 | 6,668 | 6,797 | 7,356 |
Shares Outstanding | 512.30 | 545.30 | 562.90 | 580.40 | 599.40 |
Book Value Per Share | 9.60 | 8.79 | 11.85 | 11.71 | 12.27 |
Fiscal Year End for Akzo Nobel NV falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 1,924 | 2,071 | 1,890 |
Receivables | NA | NA | 2,687 | 3,089 | 3,044 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | NA | 1,785 | 1,869 | 1,916 |
Other Current Assets | NA | NA | 145 | 171 | 167 |
Total Current Assets | NA | NA | 6,541 | 7,200 | 7,017 |
Net Property & Equipment | NA | NA | 2,158 | 2,142 | 2,133 |
Investments & Advances | NA | NA | 0 | 0 | 0 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | NA | 0 | 0 | 0 |
Intangibles | NA | NA | 4,417 | 4,518 | 4,404 |
Deposits & Other Assets | NA | NA | 2,313 | 2,193 | 2,332 |
Total Assets | NA | NA | 15,756 | 16,366 | 16,208 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 2,595 | 2,549 | 2,621 |
Accounts Payable | NA | NA | 3,174 | 3,219 | 3,089 |
Current Portion Long-Term Debt | NA | NA | 0 | 0 | 0 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | NA | 0 | 0 | 0 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | NA | 406 | 458 | 489 |
Total Current Liabilities | NA | NA | 6,176 | 6,227 | 6,199 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | NA | 1,235 | 1,130 | 1,177 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 3,425 | 3,988 | 4,015 |
Non-Current Capital Leases | NA | NA | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | NA | 10,836 | 11,344 | 11,390 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | NA | 92 | 93 | 93 |
Capital Surplus | NA | NA | 0 | 0 | 0 |
Retained Earnings | NA | NA | 0 | 0 | 0 |
Other Equity | NA | NA | 4,828 | 4,929 | 4,725 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | NA | 4,920 | 5,022 | 4,817 |
Total Liabilities & Shareholder's Equity | NA | NA | 15,756 | 16,366 | 16,208 |
Total Common Equity | 0 | 0 | 4,920 | 5,022 | 4,817 |
Shares Outstanding | 512.80 | 512.30 | 512.30 | 512.30 | 512.20 |
Book Value Per Share | 0.00 | 0.00 | 9.60 | 9.80 | 9.41 |